HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salvatore Campisi Selected Research

N-acetylVal-Nle(7,8)- allatotropin (5-13) (ATAA)

6/2021Coupling hemodynamics with mechanobiology in patient-specific computational models of ascending thoracic aortic aneurysms.
1/2020Relationship Between Ascending Thoracic Aortic Aneurysms Hemodynamics and Biomechanical Properties.
1/2020Hemodynamics alteration in patient-specific dilated ascending thoracic aortas with tricuspid and bicuspid aortic valves.
1/2019Does the Knowledge of the Local Thickness of Human Ascending Thoracic Aneurysm Walls Improve Their Mechanical Analysis?
12/2018Evaluation of Peak Wall Stress in an Ascending Thoracic Aortic Aneurysm Using FSI Simulations: Effects of Aortic Stiffness and Peripheral Resistance.
11/2018Ascending thoracic aorta aneurysm repair induces positive hemodynamic outcomes in a patient with unchanged bicuspid aortic valve.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Salvatore Campisi Research Topics

Disease

4Thoracic Aortic Aneurysm
01/2021 - 11/2018
4Rupture
01/2020 - 01/2016
2Bicuspid Aortic Valve Disease
06/2021 - 11/2018
2Aortic Valve Insufficiency (Aortic Regurgitation)
01/2016 - 11/2015
2Mitral Valve Insufficiency (Mitral Regurgitation)
12/2014 - 09/2006
1Hypertension (High Blood Pressure)
12/2018
1False Aneurysm (Pseudoaneurysm)
02/2015
1Thrombosis (Thrombus)
12/2014
1Thrombocytopenia (Thrombopenia)
12/2014
1Pathologic Constriction (Stenosis)
09/2014
1Cicatrix (Scar)
09/2006
1Cardiomyopathies (Cardiomyopathy)
09/2006
1Heart Failure
09/2006
1Coronary Artery Disease (Coronary Atherosclerosis)
09/2006
1Left Ventricular Dysfunction
09/2006
1Hemorrhage
12/2002

Drug/Important Bio-Agent (IBA)

6N-acetylVal-Nle(7,8)- allatotropin (5-13) (ATAA)IBA
06/2021 - 11/2018
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2020
1Heparin (Liquaemin)FDA LinkGeneric
12/2014
1A 19IBA
09/2014

Therapy/Procedure

2Bioprosthesis
01/2016 - 09/2014
2Therapeutics
12/2014 - 09/2006
1Prostheses and Implants (Prosthesis)
11/2015
1Punctures
02/2015
1Myocardial Revascularization
09/2006
1Heart Transplantation (Grafting, Heart)
09/2006
1Length of Stay
12/2002
1Artificial Respiration (Mechanical Ventilation)
12/2002